Top Markets
Coin of the day
Drug Free Solution, Inc. Drug Free Solution, Inc.

Drug Free Solution, Inc.

DSOL
株式のランク #40605
Based in El Segundo, California, Drug Free Solution, Inc. operates as a... Based in El Segundo, California, Drug Free Solution, Inc. operates as a lifestyle enterprise focused on emotional well-being. The company offers its proprietary "Living Breath Process," an innovative, three-stage technique that integrates self-reflection, guided breathing, and specific linguistic patterns. This method is designed to cater to various needs, including addiction prevention and recovery, personal growth, emotional health, and overall lifestyle enhancement. Beyond its core process, Drug Free Solution, Inc. also provides the "Living Breath Series" of programs, which bundles related products, educational resources, and supportive services. A significant arm of the company's mission is the "Living Breath Project." This initiative leverages distinct protocols, lifestyle-enhancing products, and comprehensive training and education to foster the establishment of community wellness centers, dedicated wellness residences, and essential support networks within correctional facilities. The overarching goal of these efforts is to significantly reduce addiction and incarceration rates across the United States. Known as Living Breath Project, Inc. until its renaming in January 2014, the company subsequently adopted its present corporate identity.
株価
$0.0004
最終同期: 2026-08-12
時価総額
$113.36K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Drug Free Solution, Inc. (DSOL)

カテゴリー

Drug Free Solution, Inc.(DSOL)のP/E比率
2026 時点のP/E比率 TTM 0
Drug Free Solution, Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は 0 です。2026 年末時点での P/E は 0 でした。
Drug Free Solution, Inc. の P/E 比率の履歴(2026 〜 2026)
各年末のP/E比率
P/E比率 変化
提供された日付のデータは十分ではありません。
類似企業や競合他社のP/E比率
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。